核医学在乳腺癌中的当前作用
本文为综述,概述过去数十年用于乳腺癌的核医学检查,重点介绍常规核医学与PET/CT的当前临床适应证,并提及放射性核素治疗(主要是骨转移疼痛姑息)及新放射性药物和定量影像生物标志物等未来方向。
要点
- 核医学在乳腺癌初始分期和随访中均有重要作用
- 综述聚焦常规核医学与PET/CT的当前临床适应证
- 放射性核素治疗主要用于姑息转移性骨痛
英文原文(摘要)· 点击展开
Breast cancer is the most common cancer in females worldwide. Nuclear medicine plays an important role in patient management, not only in initial staging, but also during follow-up. Radiopharmaceuticals to study breast cancer have been used for over 50 years, and several of these are still used in clinical practice, according to the most recent guideline recommendations.In this critical review, an overview of nuclear medicine procedures used during the last decades is presented. Current clinical indications of each of the conventional nuclear medicine and PET/CT examinations are the focus of this review, and are objectively provided. Radionuclide therapies are also referred, mainly summarising the methods to palliate metastatic bone pain. Finally, recent developments and future perspectives in the field of nuclear medicine are discussed. In this context, the promising potential of new radiopharmaceuticals not only for diagnosis, but also for therapy, and the use of quantitative imaging features as potential biomarkers, are addressed.Despite the long way nuclear medicine has gone through, it looks like it will continue to benefit clinical practice, paving the way to improve healthcare provided to patients with breast cancer.
引用
- Vaz, Oliveira, Teixeira, et al. The current role of nuclear medicine in breast cancer. Br J Radiol. 2023. PMID: 37097285. doi:10.1259/bjr.20221153
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。